ArticleBioresources and bioprocessing2026
Enhancing bioactivity of Chlorella vulgaris through enzymatic pretreatment and lactic acid fermentation.
Article in Bioresources and bioprocessing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Kinetic modelling of Chlorella spp. wastewater treatment and resource recovery in the food industry.Bioresources and bioprocessing · 2026Review
- Functional and Bioactive Properties of Fermented Microalgae and Their Biomass for Health Applications.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study explores an integrated bioprocessing approach to enhance the bioactivity of Chlorella vulgaris biomass through enzymatic pretreatment and lactic acid fermentation. Three pretreatment strategies—ultrasound-assisted hydrolysis, hydrothermal treatment, and enzymatic hydrolysis using Viscozyme, Alcalase, or their combination- were evaluated for their ability to release fermentable sugars and proteins. Enzymatic hydrolysis proved most effective, yielding up to 151.18 mg g DW− 1 of reducing sugars and 14.4 mg g DW− 1 of protein. Subsequent fermentation with Lactiplantibacillus plantarum and Levilactobacillus brevis demonstrated robust microbial growth (Δ log CFU ≈ 4.0) and significant acidification (pH 3.6–4.2), accompanied by lactic acid production up to 17.35 g/L. Functional characterisation revealed that combined enzymatic pretreatment and fermentation improved antioxidant properties, reaching values of 8.64, 19.46, 1.45 mg Trolox g DW⁻¹ in the CUPRAC, ABTS, and DPPH assays, respectively, while TPC reached 9.67 GAE g DW⁻¹. Moreover, Viscozyme-pretreated, L. plantarum-fermented samples showed inhibitory zones under non-neutralised screening conditions against Gram-positive bacteria. These findings highlight the combined effect of enzymatic pretreatment and microbial fermentation in enhancing the biofunctional value of C. vulgaris, offering a sustainable strategy for developing natural antioxidants and antimicrobial agents for food, nutraceutical, and cosmetic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.